The company priced 20 million shares at $5 each, upsized from a previously announced $75 million raise.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy
The company priced 20 million shares at $5 each, upsized from a previously announced $75 million raise.